Shenzhen biotech firm claims PCC1 capsule could extend human lifespan far beyond current limits.
A breakthrough from China’s biotechnology sector is drawing worldwide attention after researchers unveiled an anti-ageing capsule made from a natural grape-seed compound said to significantly slow cellular degeneration.
A Bold Claim in Longevity Science
China’s Lonvi Biosciences, a biotechnology company based in Shenzhen, announced early findings on a capsule developed using Procyanidin C1 (PCC1), a natural compound extracted from grape seeds. The company claims the formulation could dramatically influence ageing processes—potentially extending human lifespan toward 150 years under optimal conditions.
Understanding PCC1 and “Zombie Cells”
The PCC1 compound specifically targets senescent or “zombie” cells—ageing cells that stop dividing but continue to accumulate within tissues. These cells trigger inflammation and accelerate organ decline. By clearing or suppressing them, researchers believe the body can better maintain cellular resilience and energy production.
Strong Laboratory Findings on Mice
Lonvi Biosciences conducted laboratory studies on mice, producing results that have amplified global interest. According to the company’s report published Wednesday, 19 November, treated animals showed:
- A 9.4% increase in total lifespan
- More than a 64% rise in estimated remaining life expectancy at the start of the treatment regimen
These findings, cited by Money Control, support the scientific community’s growing focus on targeted anti-ageing interventions.
Experts Urge Caution Before Human Use
Although the mouse data is promising, Lonvi and external researchers emphasize that human trials remain essential. Comprehensive assessments of safety, long-term effects, and clinical effectiveness must be completed before any PCC1 capsule reaches commercial availability.
The Vision Behind the Pill
Lonvi CEO Ip Zhu described the formulation as “not an ordinary pill, but a miracle in longevity research.” He stated that the capsule is designed not only to extend lifespan but also to delay age-related diseases by improving cellular endurance and slowing physical degeneration. However, he clarified that reaching 150 years is not a guaranteed outcome. The pill’s full benefits would require pairing with healthy lifestyle habits and proper medical care.
Rising Global Interest in Longevity Science
The PCC1 project arrives amid a surge of international funding and attention toward anti-ageing research. Both public and private sectors in China have heavily invested in biotechnology and lifespan-extension technologies, positioning the country as a major player in next-generation health science.
Lonvi’s PCC1 capsule has sparked significant debate across Asia, particularly in countries like Indonesia and Singapore where interest in longevity, productivity, and healthy ageing continues to grow. While the promise of living to 150 remains speculative, the research underscores rapid progress in anti-ageing science—and hints at a future where extending human vitality may become a mainstream medical pursuit.
Sources: Batam Pos (2025) , Jawa Pos (2025)
Keywords: Anti Ageing Pill, PCC1 Longevity, Lonvi Biosciences, Lifespan Extension
